HBSP (USA)
-
athenahealth: Innovating in Response to a Crisis in Healthcare
Chakravorti, Bhaskar; Winig, Laura; Arastu, NaeemCase HBS-810079-EEntrepreneurshipWhen Jonathan Bush and his partner, Todd Park, realized that their revolutionary approach to delivering clinical care was being stymied by the inefficiencies in the healthcare system and insurance red tape, they turned their proprietary technology, athenaNet, to a new business, athenaHealth, that would help physicians manage their practice, billing and revenue cycles and maintain electronic patient records more efficiently and cost effectively us...Starting at €8.20
-
Blue Man Group: Creativity, Life and Surviving an Economic Meltdown
Chakravorti, Bhaskar; Kraus, Janet; Spence, Shirley M.Case HBS-810108-EEntrepreneurshipIn 2008, Blue Man Group's three co-founders are facing the prospect of losing not just a business but a way of life they have built together. The case follows the story of Chris Wink, Matt Goldman and Phil Stanton as they pursue their creative passion, and build the Blue Man Group from street performers to a performance arts empire with a global brand. The story has a personal as well as professional dimension to it, including the launch of the B...Starting at €8.20
-
Life Journey Profile: Mark Goldweitz
Chakravorti, Bhaskar; Spence, Shirley M.Case HBS-810112-EEntrepreneurshipExamine the life journey of an HBS 1969 alum, in his own words, and his perspective on success.Starting at €8.20
-
Organization and Strategy at Millennium (A)
Wulf, Julie M.; Waggoner, ScottCase HBS-710415-ELeadership and People ManagementThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to ju...Starting at €8.20
-
Organization and Strategy at Millennium (B)
Wulf, Julie M.; Waggoner, ScottCase HBS-710418-EStrategyThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to just t...Starting at €5.74
-
Innovating into Active ETFs: Factor Funds Capital Management LLC
Froot, Kenneth A.; Cohen, Lauren H.; Waggoner, ScottCase HBS-211031-EFinanceKishore Karunakaran, President and COO of FFCM, faces a variety of challenges in launching an innovative investment management business in the rapidly evolving ETF space.Starting at €8.20
-
BlackRock Solutions
Froot, Kenneth A.; Waggoner, ScottCase HBS-211082-EFinanceThe BlackRock Solutions case examines the different functions and economics of a global asset manager's value chain, with particular emphasis on the "money management" and the "investment systems platform" businesses. Students analyze why BlackRock decided to unbundle its Aladdin investment platform and if the firm should consider expanding the platform in the future. Students also explore the resulting "dual-mission" challenges of servicing both...Starting at €8.20
-
Life Journey Profile: Amee Chande
Chakravorti, Bhaskar; Spence, Shirley M.Case HBS-810110-EEntrepreneurshipExamine the life journey of an HBS 2002 alum, in her own words, and her perspective on success.Starting at €8.20
-
Dr. Cameron Powell and AirStrip Technologies: After the Apple Worldwide Developers Conference
Chakravorti, Bhaskar; Venkatraman, N.Case HBS-810143-EEntrepreneurshipDr. Cameron Powell and his partner, Trey Moore, co-founders of the innovative company, AirStrip Technologies, have developed a series of apps for the iPhone and other smartphones that can help doctors monitor the vital signs of their patients anytime, anywhere. They have presented their technology at one of the highest profile tech conferences and now face a choice of focusing on the first -- and only FDA approved -- product targeted at obstetric...Starting at €8.20